Vantrexa · SCLC · United States · Radiation oncologist · captured by James Whitfield on 12 Aug 2026 · reviewed by Dr. Sophie Laurent on 18 Aug 2026
Verbatim as captured; never edited
Radiation oncologist at Johns Hopkins raised chemotherapy-free first line during a scientific exchange. They requested supporting literature and a follow-up discussion.
Human-approved by Dr. Sophie Laurent on 18 Aug 2026
Chemotherapy-free first line: request for data reported by radiation oncologist (US).
helixor-private-llm-2026.08 · generated 12 Aug 2026, 10:00 UTC
AI summary
Chemotherapy-free first line raised by radiation oncologist; relevant for Medical Affairs.
Source spans used by the model
Radiation oncologist at Johns Hopkins raised chemotherapy-free first line during a scientific exchange. They requested supporting literature and a follow-up discussion.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Treatment pathway | Treatment pathway |
| Function | Medical Affairs | Medical Affairs |
| Priority | Medium | Medium |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 1 | 20% | 4.0 |
| Strategic alignment | 1 | 20% | 4.0 |
| Scientific importance | 4 | 15% | 12.0 |
| Urgency | 1 | 15% | 3.0 |
| Novelty | 4 | 10% | 8.0 |
| Actionability | 5 | 10% | 10.0 |
| Confidence | 5 | 5% | 5.0 |
| Breadth of occurrence | 2 | 5% | 2.0 |
| Total | Medium 48 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
10 Aug 2026 · Dr. Javier Ivanova, Johns Hopkins · MSL James Whitfield
Insight
Reviewed 18 Aug 2026 by Dr. Sophie Laurent
Action
Medical education program · Dr. Sophie Laurent · In progress
Decision
Outcome
Closure